Moderna Announces Encouraging Results For Coronavirus Vaccine

reports that drugmaker Moderna announced today that “an experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers.” According to the AP, “Study volunteers given either a low or medium dose of the vaccine...had antibodies similar to those seen in people who have recovered from COVID-19.” The AP says that “in the next phase of the study, led by the U.S. National Institutes of Health, researchers will try to determine which dose is best for a definitive experiment that they aim to start in July.” The New York Times (5/18) reports that “if those trials go well, a vaccine could become available for widespread use by the end of this year or early 2021, Dr. Tal Zaks, Moderna’s chief medical officer, said in an interview. The number of doses that could be ready is unclear, but Dr. Zaks said, ‘We’re doing our best to make it as many millions as possible.’” https://apnews.com/fc2a2346bad9e0a17917a4aa1c73607c